[Behcet's disease and associations with HLA-B5 antigen (a review of literature and the authors' findings)].
OBJECTIVE
To estimate the distribution of HLA Class I (A, B) antigens in patients with Behcet's disease (BD) and the association of HLA-B5 antigen with the clinical manifestations of the disease in different ethnic and population groups in relation to gender.


METHODS
The study covered 93 patients (68 males, 25 females) from the representatives of 24 ethnicities with the verified disease. HLA Class I antigens were typed by the microlymphocytotoxic technique, by applying an antileukocytic serum kit (GISANS, Saint Petersburg).


RESULTS
In patients with BD, the prevalence of HLA-B5 antigen proved to be significantly higher than that in the controls (72.0 and 21%, respectively) and to be similar in patients of different ethnicities living in the Caucasus and Transcaucasus (80-83%) while the number of HLA-B5 antigen-positive patients with BD was thrice less in the Russian population than in other BD patients (p < 0.01). There was a significant correlation of HLA-B5 antigen with ocular lesion (retinal angiitis) predominantly in male patients with BD.


CONCLUSIONS
The prevalence of HLA-B5 antigen was higher in patients with BD than in the population-based control. The diagnostic value of this antigen is not so great, for example, in the Russian population of patients with BD. The presence of HLA-B5 antigen in the phenotype of male patients with BD may be regarded as a prognostically poor marker of development of eye diseases.
Goloeva
R G
RG
Alekberova
Z S
ZS
Guseva
I A
IA
Krylov
M Iu
MIu
D000328:Adult; D001528:Behcet Syndrome / Q000097:blood* / Q000453:epidemiology* / Q000208:ethnology; D015415:Biomarkers / Q000097:blood; D005260:Female; D015235:HLA-B Antigens / Q000097:blood*; D006801:Humans; D008297:Male
D015415:Biomarkers; D015235:HLA-B Antigens; C035270:HLA-B5 antigen